Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
about
Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and managementOvarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerPlatelet effects on ovarian cancerEpithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescriptionImpact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic reviewUse of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studiesCancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approachesOvarian cancer epidemiology in the era of collaborative team science.Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association ConsortiumAnalgesic medication use and risk of epithelial ovarian cancer in African American women.World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research.Living in shear: platelets protect cancer cells from shear induced damage.HIF-1α binding to AEG-1 promoter induced upregulated AEG-1 expression associated with metastasis in ovarian cancer.The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary ResearchPre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancerAspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.Use of common analgesics is not associated with ovarian cancer survival.NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.IKK inhibition increases bortezomib effectiveness in ovarian cancer.Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Epidemiology of ovarian cancer: a review.Environmental (nongenetic) factors in gynecological cancers: update and future perspectives.Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium.Genetic screening for gynecological cancer: where are we heading?Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.A GPS-Based Methodology to Analyze Environment-Health Associations at the Trip Level: Case-Crossover Analyses of Built Environments and Walking.
P2860
Q26747160-E5EC33F0-56A5-431E-B43B-0EF6BB31FD77Q26747279-B1D0ABC6-3D4F-4BFE-B442-D36B514F8EC1Q26780387-7DD1ADDE-ADCE-42CE-B832-3173FF94F349Q26829401-B4CF0056-D4E5-415E-8810-D1AB2B068C13Q26858927-DA46BDB5-0670-4974-82AC-17538F03F21AQ27692649-E16BEBE2-810D-445B-B75A-B5B1BEFDE386Q28075857-8333EE46-1A5A-4AB8-A6B3-36D66E96C439Q28080472-C4BAB08E-E595-4AC5-AB9D-7EADE5ED240FQ30252987-97942DCA-20CD-4E39-9D1A-B520A5FB41BDQ30275068-97BAD475-F8ED-472C-8B48-D4905F3CDDB1Q30275751-E04DE292-BEC9-4BDB-91A8-EFD23D4CC186Q30276777-E29D8E38-F38A-4B8E-879C-A2BB81971835Q30277284-AB9E5E92-3C5D-47CF-8EA6-EB6E2C691502Q30855249-AB6134E6-CAFB-4909-B188-FF72BFBDF87AQ33415986-F5A2623D-64D1-40D6-91C6-7C08AB6B4DB1Q33679589-3430EB7A-528C-4530-85EA-5394CF866912Q33825423-85303EAC-9604-4795-AAE0-01C0603E8F47Q34624404-5019A87E-7E43-473E-9E0F-9DC120AAB7A7Q35155614-92F17DA8-3020-42C9-A083-F253198741AAQ35274864-EEEDEFA0-06BD-4953-9948-8DD1300EFA7CQ35631181-0711D258-CF80-4A2F-9C54-DFA6B3D2D696Q35768450-21AD6850-F847-47FA-BD7C-EDB68D51906FQ35920931-A88BD7F2-DD11-4884-ADE9-858F409E04FEQ36017220-11050C1C-2A1D-4000-A8E0-D83ABD11E137Q36313479-4C040133-4945-4306-B70F-ED68CD7B28CAQ36413454-F9D68C7D-ED80-4DF1-BAC3-0EC2DE0D9481Q36772925-DC59887D-5127-47C0-8416-10AFE265DE12Q37234793-A16A7C70-FBA1-4AC7-BA60-8FA556CE198AQ37624504-E66918FB-BA90-4EC1-B76A-D815992DC751Q37720438-AE3893D9-0515-4C3C-8958-8EE181B3C31CQ38319580-1365CC05-7ED4-445B-BA29-26CB8ED46E1DQ38358175-684A7B8D-CB79-4AB5-9E6B-15F0F3E33565Q38545163-E84F9BFA-36C0-4AB1-868B-A2BD67BD7370Q38554955-D3E9756B-B48C-4BC9-B5CC-A20B359DFFCEQ38638265-DA4627B9-DBAC-43A8-81DE-DD0665A4EC44Q38659935-5ADB861C-B599-4CB1-B0B5-9147E623B033Q38745843-D154A0BE-DC79-4993-953D-A22E7D8AB9FFQ38870982-96B34F36-7A54-4371-BA69-96443E079D26Q39326953-24D93300-A368-48A9-A4D3-27FB91433935Q39360191-59D5B6F5-553B-4528-84C6-6EEC72E6477E
P2860
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@en
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@nl
type
label
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@en
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@nl
prefLabel
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@en
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@nl
P2093
P2860
P50
P921
P356
P1476
Aspirin, nonaspirin nonsteroid ...... Cancer Association Consortium.
@en
P2093
Allison Vitonis
Andrew Berchuck
Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer)
Britton Trabert
Celeste Leigh Pearce
Christina M Nagle
Daniel W Cramer
Elizabeth M Poole
Ellen L Goode
P2860
P304
P356
10.1093/JNCI/DJT431
P407
P50
P577
2014-02-01T00:00:00Z